West Pharmaceutical Services, Inc. and its majority-owned subsidiaries is a
manufacturer of packaging components and delivery systems for injectable drugs
and healthcare products. Our products include vial containment solutions, prefillable
systems, self-injection platforms, cartridge systems and components, reconstitution
and transfer systems, intradermal delivery solutions, specialty components,
and contract manufacturing and analytical services. Our customers include the
leading biologic, generic, pharmaceutical, diagnostic, and medical device companies
in the world. The Company was incorporated under the laws of the Commonwealth
of Pennsylvania on July 27, 1923.
In 2015, our business operations consisted of two reportable segments, the
Pharmaceutical Packaging Systems segment (“Packaging Systems”) and
the Pharmaceutical Delivery Systems segment (“Delivery Systems”).
Beginning in 2016, we changed our organization and reporting structure for our
next phase of growth and development, which resulted in a change to Proprietary
Products and Contract-Manufactured Products as our reportable segments.
Proprietary Products Segment
Our Proprietary Products reportable segment, which is a combination of the
previous Packaging Systems segment and the proprietary products portion of the
previous Delivery Systems segment, develops commercial, operational, and innovation
strategies across our global network, with specific emphasis on product offerings
to biologic, generic, and pharmaceutical drug customers.
Proprietary Products offers proprietary packaging, containment and drug delivery
products. The packaging products include stoppers and seals for injectable packaging
systems, which are designed to help ensure drug compatibility and stability,
while also supporting operational efficiency. Proprietary Products also offers
syringe and cartridge components, including custom solutions for the specific
needs of injectable drug applications, as well as administration systems that
can enhance the safe delivery of drugs through advanced reconstitution, mixing
and transfer technologies.
In 2016, we announced the availability of the 1-3mL NovaPure® plunger,
an innovative, high-quality component for pre-filled delivery systems, designed
to reduce particulates, ensure consistency of delivery and fit the changing
needs of higher-volume injectable drug delivery systems. This new offering adds
to our current portfolio of NovaPure products, which includes the 1mL long NovaPure
plunger and 13mm and 20mm NovaPure lyo and serum stoppers. Our NovaPure plungers
are designed and manufactured using scientific, risk-mitigating Quality by Design
principles to ensure dimensional control and consistency, sub-visible and visible
particulate control, and low parts per million defect attributes.
We also offer drug containment solutions, including CZ vials, syringes and
cartridges, which can provide a high-quality solution to glass incompatibility
issues and can stand up to cold storage environments, while reducing the risk
of breakage that exists with glass. It is an integrated life-cycle solution
that is designed to maintain drug safety, purity and efficacy.
In addition, we offer a variety of self-injection systems, which are innovative,
patient-centric technologies that are easy to use and can be combined with connected
health technologies that have the potential to increase adherence.
The development of our SmartDose® technology platform continues to gain
momentum in the marketplace, as the U.S. Food and Drug Administration (“FDA”)
approved the first combination product that incorporates our SmartDose technology
for use in the U.S. in July 2016, and several other active development programs
are in place. This technology platform is designed for controlled, subcutaneous
delivery of high volume and high viscosity drugs, and the device incorporates
prefillable CZ cartridges. The technology platform is fully programmable, has
a single push-button operation and a hidden needle for safety.
Our Contract-Manufactured Products reportable segment, which consists of the
contract manufacturing portion of the previous Delivery Systems segment, serves
as a fully integrated business focused on the design, manufacture, and automated
assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical
device customers.
Contract-Manufactured Products includes a variety of custom contract-manufacturing
and assembly solutions, which use such technologies as multi-component molding,
in-mold labeling, ultrasonic welding and clean room molding and device assembly.
We manufacture customer-owned components and devices used in surgical, diagnostic,
ophthalmic, injectable, and other drug delivery systems, as well as consumer
products.
